Prediction of steady-state volume of distribution of acidic drugs by quantitative structure-pharmacokinetics relationships.
暂无分享,去创建一个
[1] Franco Lombardo,et al. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. , 2004, Journal of medicinal chemistry.
[2] Jin Sun,et al. Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. , 2009, European journal of medicinal chemistry.
[3] R. Rondanelli,et al. A Clinical and Pharmacokinetic Study , 1983 .
[4] W. Shelver,et al. Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. , 1995, Journal of pharmaceutical sciences.
[5] U. Fagerholm,et al. Prediction of human pharmacokinetics – evaluation of methods for prediction of volume of distribution , 2007, The Journal of pharmacy and pharmacology.
[6] E. Li,et al. Zoledronic acid: a new parenteral bisphosphonate. , 2003, Clinical therapeutics.
[7] Donald E Mager,et al. Quantitative structure-pharmacokinetic/pharmacodynamic relationships. , 2006, Advanced drug delivery reviews.
[8] Snezana Agatonovic-Kustrin,et al. Multiple pharmacokinetic parameter prediction for a series of cephalosporins. , 2003, Journal of pharmaceutical sciences.
[9] Malcolm Rowland,et al. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications , 1980 .
[10] T. Wilson,et al. Ridogrel: An Antiplatelet Agent with Antihypertensive Properties , 2006 .
[11] Panos Macheras,et al. Multivariate Statistics of Disposition Pharmacokinetic Parameters for Structurally Unrelated Drugs Used in Therapeutics , 2002, Pharmaceutical Research.
[12] J. V. Turner,et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.
[13] P. Newton,et al. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria , 2006, European Journal of Clinical Pharmacology.
[14] Qigui Li,et al. The evaluation of radiolabeled artesunate on tissue distribution in rats and protein binding in humans. , 2006, The American journal of tropical medicine and hygiene.
[15] M. Orme,et al. The interaction between indomethacin and probenecid; A clinical and pharmacokinetic study , 1978, Clinical pharmacology and therapeutics.
[16] N. Davies,et al. Choosing the Right Nonsteroidal Anti-Inflammatory Drug for the Right Patient , 2000, Clinical pharmacokinetics.
[17] Taravat Ghafourian,et al. QSPR models for the prediction of apparent volume of distribution. , 2006, International journal of pharmaceutics.
[18] A. Schweitzer,et al. Biodistribution and Plasma Protein Binding of Zoledronic Acid , 2008, Drug Metabolism and Disposition.
[19] Y. Yano,et al. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state , 2003, The Journal of pharmacy and pharmacology.
[20] R. Slaughter,et al. The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics , 2004, European Journal of Clinical Pharmacology.
[21] Franco Lombardo,et al. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. , 2002, Journal of medicinal chemistry.
[22] Lemont B. Kier,et al. Intermolecular Accessibility: The Meaning of Molecular Connectivity , 2000, J. Chem. Inf. Comput. Sci..
[23] A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin , 2002, Journal of clinical pharmacology.
[24] J. Freidman,et al. Multivariate adaptive regression splines , 1991 .
[25] W. Jusko,et al. Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in man. , 2002, Journal of pharmaceutical sciences.
[26] D. Tashkin. Multiple dose regimens. Impact on compliance. , 1995, Chest.
[27] K. Lees,et al. Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke , 2000, European Journal of Clinical Pharmacology.
[28] R. Boggia,et al. Genetic algorithms as a strategy for feature selection , 1992 .
[29] U. Kragh-Hansen,et al. Complexes of aliphatic sulfates and human-serum albumin studied by 13C nuclear-magnetic-resonance spectroscopy. , 1976, European journal of biochemistry.
[30] Hans Lennernäs,et al. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[31] Patrick Poulin,et al. Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. , 2002, Journal of pharmaceutical sciences.
[32] Alexander Tropsha,et al. Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods. , 2004, Journal of pharmaceutical sciences.
[33] M. Cronin,et al. Quantitative structure‐pharmacokinetic relationship modelling: apparent volume of distribution , 2004, The Journal of pharmacy and pharmacology.
[34] B. Barlogie,et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. , 1989, Blood.
[35] F. Wingen,et al. Pharmacokinetics of the osteotropic diphosphonate 3-amino-1-hydroxypropane-1,1-diphosphonic acid in mammals. , 1987, Arzneimittel-Forschung.
[36] L. H. Hall and L.B. Kier. Molecular Connectivity Chi Indices for Database Analysis and Structure-Property Modeling , 2000 .
[37] R. Benjamin,et al. Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials. , 1985, Cancer research.
[38] A. Tsantili-Kakoulidou,et al. Quantitative structure-pharmacokinetic relationships for disposition parameters of cephalosporins. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] C. Löwik,et al. The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen‐Containing Bisphosphonates , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] M Danhof,et al. Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat. , 1999, Journal of pharmaceutical sciences.
[41] Franco Lombardo,et al. A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. , 2006, Journal of medicinal chemistry.
[42] H. Neu,et al. Kinetics of mezlocillin and carbenicillin , 1978, Clinical pharmacology and therapeutics.
[43] S Oie,et al. Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.
[44] Paul D. Martin,et al. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. , 2003, Clinical therapeutics.
[45] M Paul Gleeson,et al. In silico human and rat Vss quantitative structure-activity relationship models. , 2006, Journal of medicinal chemistry.
[46] Marilyn E. Morris,et al. Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure–Pharmacokinetic Relationships , 2009, The AAPS Journal.
[47] Franco Lombardo,et al. In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. , 2009, Journal of medicinal chemistry.
[48] H. Hasegawa,et al. Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[49] Franco Lombardo,et al. Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds , 2008, Drug Metabolism and Disposition.